ASCO publishes a suite of peer-reviewed journals with content focused on

  • clinical oncology research;
  • issues and insights affecting oncology practice;
  • cancer care, research and care delivery issues unique to countries and settings with limited healthcare resources;
  • biomedical informatics methods and processes applied to cancer-related data, information, and images; and
  • the science and practice of precision oncology.

ASCO’s peer-reviewed journals follow a continuous publication schedule. Below is a select list of the newest content from ASCO’s journals. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author.

ASCO occasionally highlights select journal articles in an embargoed press release known as a News Digest or in a Featured Article summary. Sign up to receive communications regarding these articles.

Embargoed until June 15, 4:00 PM ET:

Patient HLA Germline Variation and Transplant Survivorship (JCO: Original Report) 
Effie Petersdorf, et al.
Request this article

Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial (JCO: Original Report)
Myung-Ju Ahn, et al.
Request this article

Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer (JCO: Original Report) 
Lauren Byers, et al.
Request this article

The State of Oncology Practice in America, 2018: Results of the ASCO Practice Census Survey (JOP: Original Contribution) 
M. Kelsey Kirkwood, et al.
Request this article

An Analysis of Social Science Research Into Cancer Care in Low- and Middle-Income Countries: Improving Global Cancer Control Through Greater Interdisciplinary Research (JGO: Special Article)
Carlo Caduff, et al.
Request this article

Barriers to Cervical Cancer Screening and the Cervical Cancer Care Continuum in Rural Guatemala: a Mixed Method Analysis (JGO: Original Report)
Peter Rohloff, et al.
Request this article

Embargoed until June 14, 4:00 PM ET:

Patient HLA Germline Variation and Transplant Survivorship (JCO: Original Report) 
Effie Petersdorf, et al.
Request this article

Monitoring of Technology Adoption Using Web Content Mining of Location Information and Geographic Information Systems: A Case Study of Digital Breast Tomosynthesis (JCO CCI: Original Report)
Jennifer Alford-Teaster
Request this article

Embargoed until June 13, 4:00 PM ET:

Transcriptional Subtyping and CD8 Immunohistochemistry Identifies Poor Prognosis Stage II/III Colorectal Cancer Patients who Benefit From Adjuvant Chemotherapy (JCO PO: Original Report)
Daniel Longley, et al.
Request this article

Multi-Gene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes (JCO PO: Original Report)
Fergus Couch, et al.
Request this article

Embargoed until June 12, 4:00 PM ET:

Efficacy of Exercise Therapy on Cardiorespiratory Fitness in Patients With Cancer: A Systematic Review and Meta-Analysis (JCO: Original Report)
Jessica Scott, et al.
Request this article

Delivery of Pediatric Cancer Care in Mexico: A National Survey (JGO: Original Report)
Alberto Olaya-Vargas, et al.
Request this article

Validation of the Survival Benefits of Metformin in Middle Eastern Patients with Type II Diabetes Mellitus and Colorectal Cancer (JGO: Original Report)
Amal Al Omari, et al.
Request this article

Embargoed until June 11, 4:00 PM ET:

Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline (JCO: ASCO Special Article)
Kari Bohlke, et al.
Request this article

Embargoed until June 8, 4:00 PM ET:

Frequent HIV and Young Age Among Individuals with Diverse Cancers at a National Teaching Hospital in Malawi (JGO: Original Report)
Marie-Josephe Horner, et al.
Request this article

Ramucirumab Safety in East Asian Patients: A Meta-Analysis of Six Global, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trials (JGO: Original Report)
Hyun Cheol Chung, et al.
Request this article

Are Global Breast Cancer Incidence and Mortality Patterns Related to Country-Specific Economic Development and Prevention Strategies? (JGO: Original Report)
Aymen Elfiky, et al.
Request this article

Embargoed until June 7, 4:00 PM ET:

Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial (JCO: Rapid Communications)
Jonathan Strosberg, et al.
Request this article

Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial (JCO: Original Report)
Jean Bourhis, et al.
Request this article

An Applied Informatics Decision Support Tool for Mortality Predictions in Cancer Patients (JCO CCI: Original Report)
Aymen Elfiky, et al.
Request this article

Embargo Information

The embargo date and time of a journal article coincide with its online publication date and time. Journalists may conduct embargoed interviews with study authors up to one week prior to the online publication date. ASCO takes embargo violations seriously and violations typically result in the loss of journal media privileges for a period of one year and may affect broader ASCO media privileges as well. Journalists may request embargoed articles. Please direct further questions regarding the embargo policies for ASCO Journals to the Media Team.